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There has been an increasing concern with the problem of device-related infections,
ever since foreign materials such as metal or plastic began to be used in implant
surgery. The prophylaxis and treatment of such infections is difficult to evaluate in
clinical studies, because placebo-controlled prophylaxis trials are thought to be
unethical, and no single centre has enough patients for comparative treatment
studies. For this reason different experimental models have been developed to study
aspects of device-related infections. In this review, these infection models are
presented. Different applications of the tissue-cage guinea pig model are summar-
ized. This model allows the study of pathogenesij, natural course, prophylaxis, and
treatment of device-related infection. In addition, by using this infection model,
novel microbiological in-vitro tests could be developed, and questions of biocorn-
patibility analysed.
Introduction
During the last four decades, metals or plastics have been increasingly used for
different types of devices (Ingraham, Alexander & Matson, 1947; Pudenz et al., 1957;
Chamley, 1972; Szilagyi et al., 1972). Of all problems associated with such implants,
the most severe is infection. The commonest microorganisms involved in such infec-
tions are Staphylococcus aureus, Staphylococcus epidermidis and Escherichia coli.
However, any microorganism may be implicated (Andrews et al., 1981; Widmer et al.,
1990a). Without removal of the foreign material, antimicrobial therapy often fails to
cure device-related infections (Dougherty, 1988).
During the last ten years, different experimental models have been used to elucidate
the multiple problems encountered in device-related infections (Zimmerli et al., 1982;
Zimmerli, Lew & Waldvogel, 1984; Zimmerli, Zak & Vosbeck, 1985; Widmer et al.,
19906, 1991). Whereas in the early eighties the main research effort was directed to the
study of pathogenesis (Zimmerli et al., 1982, 1985), within the last five years much has
been learned about drug therapy and prophylaxis of device-related infection
(Bouchenaki et al., 1990; Widmer et al., 19906, 1991).
Animal models of device-related infections
Suture model
James & MacLeod (1961) developed the stitch abscess model in the mouse. In their
experimental model of superficial skin infection, they could show that the presence of
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suture material decreased the abscess-forming dose from 107 cfu to 102 cfu of S. aureus.
Despite a heavy granulocyte infiltration surrounding the suture, the infection could not
be eliminated. With these experiments, the high susceptibility to infection, and the
persistence of established infection, could be experimentally demonstrated for the first
time.
Following these experiments, the same experimental model was used to analyse the
infection potentiating properties of different suture materials (Katz, Mordechai &
Mirelman, 1981).
Vascular graft model
After the introduction of vascular grafts in clinical medicine, the problem of vascular
graft infection was studied in experimental models. Dogs are the experimental animals
commonly used (Busuttil et al., 1979). Other experimental animals that have been
used are pigs, minipigs, calves and baboons (Kron et al., 1980). The following aspects
have been studied using the vascular graft model: healing characteristics (e.g. the
influence of pseudointimal integrity on susceptibility to infection) the influence of
material on development of infection, and the pathogenesis of haematogenous
infections.
Catheter and prosthetic valve endocarditis model
Garrison & Freedman (1970) developed the first model of endocarditis. They used a
catheter to induce and maintain endocarditis in rabbits. With a similar model in rats,
aspects of endocarditis prophylaxis have been extensively studied (Glauser et al., 1983).
These models gave the rational background for the recommendations regarding
antimicrobial prophylaxis for the prevention of bacterial endocarditis. In another, more
sophisticated model, tricuspid prosthetic valve endocarditis was studied in calves
(Grogan et al., 1980). This model can be used to study the technical problems of
prosthetic-valve replacement, the quality of different prosthetic materials and the
natural history of prosthetic-valve endocarditis, and to test the efficacy of antibiotic
prophylaxis and treatment.
Knee joint model
Blomgren et al. (1981) implanted finger endoprostheses into rabbit knees in order to
study haematogenous infections in the joint implant. The same model is useful for the
systematic study of antibiotic prophylaxis.
Tissue cage model
The tissue-cage model has been developed to study various aspects of prosthetic
infections, including the pathogenetic mechanisms leading to the high susceptibility of
implanted devices to infection and their persistence (Zimmerli et al., 1982, 1984, 1985).
In this model, perforated polymer cylinders are subcutaneously implanted into guinea
pigs.
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Table. Application of the tissue-cage model
Clinical problem References
Local immune deficiency Zimmerli et al. (1982, 1984)
Risk of haematogenous seeding on Zimmerli et al. (1985)
extravascular devices
Efficacy of prophylaxis Tshefu et al. (1983), Zimmerli et al. (1984),
Widmer et al. (1991)
Efficacy of therapy Tshefu et al. (1983), Zimmerli et al. (1985),
Widmer et al. (1990aA 1991), Bouchenaki
et al. (1990)
Correlation between drug efficacy in vivo and Widmer et al. (1990a, 1991), Vergeres et al.
in device-related infections (1992)
Testing of biomaterials Widmer et al. (1992)
(biocompatibility, susceptibility to
infection)
Application of tbe tissue-cage model
The Table shows different aspects that have been studied with the tissue-cage model.
Study of the pathogenesis of device-related infections
Tissue cages are subcutaneously implanted into guinea pigs. This imitates the clinical
situation of extravascular devices such as pacemaker batteries, subcutaneous catheters
and shunts, breast implants, etc. The accumulation of interstitial fluid and leucocytes in
the vicinity of the tissue cage allows study of local host defence mechanisms. We
observed a locally acquired granulocyte defect which may be responsible for the high
susceptibility of implants to infection (Zimmerli et al., 1982, 1984). There is evidence
that this defect is a consequence of the prolonged stimulation of the granulocyte by the
non-phagocytosable implant.
Haematogenous implant infection
Whereas infection up to one year after surgery is mostly due to intra-operative
contamination, little is known about the pathogenesis of late prosthetic infections. We
employed the tissue-cage model to determine whether extravascular devices could be
infected by the haematogenous route (Zimmerli et al., 1985). Intracardiac inoculation
of 50 million cfu 5. aureus Wood 46, resulting in bacteracmias of lOMO3 cfu/mL, led
to selective infection in 42% of the tissue cages without microbiological evidence of
infection elsewhere. These experiments indicate that antibiotic prophylaxis might be
considered in patients with extravascular devices undergoing procedures complicated
by bacteraemia.
Efficacy of prophylaxis
The tissue-cage model described can be used to analyse the conditions for adequate
antimicrobial prophylaxis. By testing different time intervals between bacterial inocula-
tion and start of treatment, the importance of timely prophylaxis and the need for
multiple doses could be evaluated (Tshefu et al., 1983; Zimmerli et al., 1985). In tissue
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cages which were directly inoculated with S. aureus Wood 46, prophylaxis with four
doses of rifampicin was 100% efficient before and up to 3 h after, but only 57%
efficient 24 h after bacterial challenge (Tshefu et al., 1983). With doses of rifampicin
starting either before, or up to 3 h after, experimental bacteraemia with 5. aureus, no
implant infection occurred (Zimmerli et al., 1985). Similar results were obtained with
E. coli as the test strain (Widmer et al., 1991).
Efficacy of therapy
Device-related infections tend to persist despite treatment with an antibiotic with
excellent in-vitro activity (Dougherty, 1988; Widmer et al., 1990a). We therefore
analysed the efficacy of different antimicrobial drugs against S. epidermidis (Widmer
et al., 19906), S. aureus (Zimmerli et al., 1991), E. coli Widmer et al., 1991), and
Salmonella dublin (Widmer et al., 1990a). The main finding in these studies was that
rifampicin-containing regimens were much more efficient against staphylococci than
any other drug (Widmer et al., 1990*; Zimmerli et al., 1991). However, rapid emer-
gence of resistance was observed if rifampicin was given alone (Zimmerli et al., 1991).
In Gram-negative infections, quinoloncs were the most efficient drugs (Widmer et al.,
1990a, 1991).
Development of in-vitro tests to predict drug efficacy in device-related infection
The choice of a therapeutic antimicrobial agent is usually guided by the in-vitro
susceptibility (MIC) of the microorganism to the drug. In treating device-related
infections, this choice is obviously often not adequate, since the infection persists,
regardless of the length of the treatment (Widmer et al., 1990a). We therefore looked
for more appropriate in-vitro tests which take into account the special situation of
device-related infections. In these infections bacteria are likely to be in the stationary
phase of growth, against which all antibiotics show a diminished activity. Furthermore,
bacterial adherence to foreign materials alters their susceptibility to antimicrobial
agents.
We used the tissue-cage model to validate novel microbiological tests taking into
account the above mentioned properties of the microorganisms. These studies showed
that drug efficacy on stationary and adherent microorganisms, but not MICs, predicted
the outcome of device-related infection (Widmer et al., 1990a, 1991; Vergeres et al.,
1992).
Tests of biocompatibility
Most biocompatibility tests are performed with cell culture systems and/or histology
specimens from animals with bioimplants. However, these tests do not allow evaluation
of the correlation between biocompatibility and infection susceptibility of foreign
materials.
We used the tissue-cage model to study this correlation. By implanting two different
materials (Teflon and ceramic), we tested the minimal infecting dose on the one hand,
and the degree of inflammation (leucocyte counts and protein levels in tissue-cage fluid)
on the other hand. In a first study we could show a direct correlation between
biocompatibility and resistance to infection. Ceramic tissue cages provoked more
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inflammation, but were ten times more susceptible to infection with S. epidermidis than
Teflon cages (Widmer et al., 1992).
Conclusions
The use of animal models has allowed us an insight into pathogenesis, prophylaxis, and
treatment of device-related infections. As soon as a reproducible in-vitro test allows
prediction of the efficacy of antimicrobial drugs in such infections, animal experiments
will be redundant. However, the tissue-cage model will still be useful to test the relation
between biocompatibility and infection susceptibility of different clinically important
biomaterials.
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